Global Antifungal Market: Industry Analysis & Outlook (2016-2020) - Increased Awareness of Fungal Infections to Drive Market - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Antifungal Market: Industry Analysis & Outlook (2016-2020)" report to their offering.

Fungal infections have become quite common; affecting 20-25% of the general population. The occurrence of fungal infections has amplified intensely over the past few decades due to the increase in the number of the population vulnerable to such infections. This population comprises of individuals undertaking chemotherapy for cancer, individuals with AIDS, those receiving transplantation for heart or any other surgery. Increased awareness regarding the antifungal drugs will bring about immense changes in the market.

Fungal infections are often regarded as opportunistic or primary. They can affect many areas of the body, or only one. There are different antifungal preparations that are used to treat fungal infections. They are either applied directly to a fungal infection of the skin or other surface, or taken orally. For serious infections, several months of treatment might be needed.

North America is the leading region in antifungal market owing to the mounting public private trust in the pharmaceutical industry and the intensifying popularity of over-the-counter antifungal drugs to cure infections. In addition to this, rising population with weak immune system because of cancer chemotherapy in which the fungal infections occur more regularly than normal is driving the market in North America.

The key growth factors of the anti-fungal market include rise in incidences of fungal infections in immuno-compromised patients, increase in number of cancer patients, rise in incidences of fungal Infections in people suffering from AIDS, increase in spending's on medicines, rise in sale of prescription drugs and many more. However, market growth is hindered by the factors such as harsh side effects of drugs, drug resistance, high cost of anti-fungal, and lack of new anti-fungal therapies.

Companies Mentioned:

  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.

Key Topics Covered:

1. Market Overview

2. Global Antifungal Market

3. Global Invasive Antifungal Market

4. Regional Anti-Fungal Market Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/pfqzqq/global_antifungal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Over the Counter (OTC) Drugs